Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-02-13 4:31:55 am | CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma | GlobeNewsWire |
| 2024-02-05 5:0:0 am | Candel Therapeutics Sets Path to Success: Recent Achievements Pave the Way for a Promising 2024 Propelled by Key Value Drivers and Catalysts | GlobeNewswire |
| 2023-12-13 9:21:0 am | Candel (CADL) Rises on FDA's Fast Track Status for CAN-2409 | Zacks |
| 2023-12-12 5:0:0 am | Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer | GlobeNewswire |
| 2023-11-28 6:0:0 am | Candel Therapeutics Announces Restructuring to Prioritize Resources on Key Value Drivers for Expanded Development of CAN-3110, the enLIGHTEN™ Discovery Platform, and Key Clinical Readouts for CAN-2409 | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information